TriangleFOR PATIENTS · SOURCE READING
Treatment Option Overview for LCH
Source: Langerhans Cell Histiocytosis Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: June 6, 2024 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
Continue within this section
Key Points →There are different types of treatment for patients with Langerhans cell histiocytosis (LCH). →Children with LCH should have their treatment planned by a team of health care providers who are experts in treating childhood cancer or LCH. →Nine types of standard treatment are used to treat LCH. →New types of treatment are being tested in clinical trials. →Treatment for Langerhans cell histiocytosis may cause side effects. →Patients may want to think about taking part in a clinical trial. →Patients can enter clinical trials before, during, or after starting their treatment. →Follow-up tests may be needed. →
Preserved source evidence · Independent clinical review pending · Not medical advice